Caplin Point Laboratories Share Price Targets
Caplin Point Laboratories Limited | |||
 | Price: ₹2,036.90 (-6.72%) | ||
| 52 Week Low: ₹1,599.00 52 Week High: ₹2,641.00 | |||
| Market Capital: 15,125.73 Crore (Midcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Caplin Point Laboratories Stock Comparison: Caplin Point Laboratories vs Suven Pharmaceuticals | Caplin Point Laboratories vs Granules India | Caplin Point Laboratories vs AstraZeneca Pharma | Caplin Point Laboratories vs Marksans Pharma | Caplin Point Laboratories vs Glenmark Life Sciences | Caplin Point Laboratories vs Poly Medicure | |||
Share Price HistoryCAPLIPOINT FinancialsTomorrow TargetYearly TargetsDividend HistoryNo BonusSplit History
Show Table of Contents
Table of Contents
Caplin Point Laboratories Recent Performance
Over the past 465 trading days, the value of Caplin Point Laboratories's stock has gained ₹960.95 (+89.31%). On 07 Nov 2023, one share was worth ₹1075.95 and by 26 Sep 2025, the value jumped to ₹2036.90. During this period it created a highest high of ₹2641.00 and lowest low of ₹1054.00.
Caplin Point Laboratories Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 2168 (+6.43%) | Price Action: 02 Jun 2025 High |
| Tomorrow Target 2 | 2146.5 (+5.38%) | Price Action: 30 May 2025 Low |
| Tomorrow Target 1 | 2125 (+4.32%) | Price Action: 17 Jul 2025 High |
| Current Price | 2036.90 | Caplin Point Laboratories's share price as of 26 Sep 2025 |
| Stop Loss 1 | 1954.9 (-4.03%) | Price Action: Jul 2025 Low |
| Stop Loss 2 | 1935.19 (-5%) | Fibonacci Retracement Level 78.60% |
| Stop Loss 3 | 1914.55 (-6.01%) | Price Action: Nov 2024 Low |
Summary
26 Sep 2025: Caplin Point Laboratories finished the day at ₹2036.90, losing ₹-146.70 (-6.72%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -6.01% to 6.44% with:
- Target prices: ₹2125 to ₹2168
- Support levels: ₹1954.9 to ₹1914.55
- Recent high: ₹2149.90
- Recent low: ₹2005.10
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Caplin Point Laboratories Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 2165 (+6.28%) | Price Action: 25 Sep 2025 Low |
| Next Week Target 2 | 2142.1 (+5.16%) | Price Action: 03 Jun 2025 Low |
| Next Week Target 1 | 2119 (+4.03%) | Price Action: 09 Jun 2025 High |
| Current Price | 2036.90 | Caplin Point Laboratories's share price as of 26 Sep 2025 |
| Stop Loss 1 | 2011.1 (-1.27%) | Price Action: 09 Jul 2025 Low |
| Stop Loss 2 | 1990 (-2.31%) | Price Action: 03 Jul 2025 Low |
| Stop Loss 3 | 1958.7 (-3.84%) | Price Action: 15 May 2025 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -3.84% to 6.29% with:
- Upper targets: ₹2119 to ₹2165
- Support levels: ₹2011.1 to ₹1958.7
Caplin Point Laboratories Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 2193.8 (+7.7%) | Price Action: 10 Sep 2025 Low |
| Next Month Target 2 | 2171 (+6.58%) | Price Action: 30 Jun 2025 High |
| Next Month Target 1 | 2149 (+5.5%) | Price Action: 13 Jun 2025 High |
| Current Price | 2036.90 | Caplin Point Laboratories's share price as of 26 Sep 2025 |
| Stop Loss 1 | 2005.1 (-1.57%) | Price Action: Sep 2025 Low |
| Stop Loss 2 | 1982.34 (-2.68%) | Price Action: Aug 2024 High |
| Stop Loss 3 | 1958.7 (-3.84%) | Price Action: 15 May 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -3.84% to 7.70% with:
- Target range: ₹2149 to ₹2193.8
- Support levels: ₹2005.1 to ₹1958.7
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
